Apexigen Inc (APGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,042 | -28,916 | -20,823 | -452 | -170 |
| Depreciation Amortization | 46 | 309 | 239 | N/A | N/A |
| Accounts payable and accrued liabilities | -402 | 841 | 33 | 27 | 7 |
| Other Working Capital | 135 | 3,034 | 516 | -54 | -149 |
| Other Operating Activity | 923 | 830 | 1,281 | 162 | 64 |
| Operating Cash Flow | $-8,340 | $-23,902 | $-18,754 | $-317 | $-248 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -43 | -54 | -54 | N/A | N/A |
| Purchase Of Investment | -8,937 | -20,179 | -20,179 | N/A | N/A |
| Sale Of Investment | 11,500 | 42,257 | 33,380 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -58,075 | -58,075 |
| Investing Cash Flow | $2,520 | $22,024 | $13,147 | $-58,075 | $-58,075 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,470 | N/A |
| Debt Repayment | N/A | N/A | N/A | -116 | -116 |
| Common Stock Issued | 50 | 98 | 99 | 57,500 | 59,970 |
| Other Financing Activity | -122 | -61 | -50 | -1,111 | -1,111 |
| Financing Cash Flow | $-72 | $37 | $49 | $58,743 | $58,743 |
| Beginning Cash Position | 23,443 | 25,284 | 25,284 | 1 | 1 |
| End Cash Position | 17,551 | 23,443 | 19,726 | 352 | 421 |
| Net Cash Flow | $-5,892 | $-1,841 | $-5,558 | $351 | $420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,340 | -23,902 | -18,754 | -317 | -248 |
| Capital Expenditure | -43 | -54 | -54 | N/A | N/A |
| Free Cash Flow | -8,383 | -23,956 | -18,808 | -317 | -248 |